Juvenescence en route to listing

Jim Mellon has announced plans to take the longevity firm Juvenescence public within the next 6-12 months. Talking to CNBC earlier this week, Jim said that a number of investment banks have approached the company and that Juvenescence has identified the partners that it is interested in working with for the listing process. The company, which has holdings in businesses including Insilico Medicine and AgeX Therapeutics, will most likely be listed in the US, although no final decision has been reached.

Jim Mellon commented: “We are likely, within the next six months to a year, to be a public company assuming everything goes well and markets don’t collapse etc“.